In the study of synovial sarcoma, the SS18-SSX fusion protein would induce aberrant YAP/TAZ signals (71) and associated with SWI/SNF and Polycomb chromatin complexes to dysregulate gene expression (74–76), which might provide ideas for the aberrant alternation of SS18 in MP-LUAD. Here, SMARCA1 is linked to synovial sarcoma.